Patents Assigned to Seyltx, Inc.
  • Patent number: 12478618
    Abstract: The use of glutamate 2b receptor antagonists and sigma receptor agonists as antitussives to treat or prevent a cough is disclosed. In preferred embodiments, the glutamate 2b receptor antagonist is ifenprodil or radiprodil. Preferred sigma receptor agonists include fluvoxamine, fluoxetine, excitalpram, and donepezil.
    Type: Grant
    Filed: August 21, 2024
    Date of Patent: November 25, 2025
    Assignee: Seyltx, Inc.
    Inventor: Mark Williams
  • Patent number: 12472170
    Abstract: The use of glutamate 2b receptor antagonists and sigma receptor agonists as antitussives to treat or prevent a cough is disclosed. In preferred embodiments, the glutamate 2b receptor antagonist is ifenprodil or radiprodil. Preferred sigma receptor agonists include fluvoxamine, fluoxetine, excitalpram, and donepezil.
    Type: Grant
    Filed: March 6, 2020
    Date of Patent: November 18, 2025
    Assignee: Seyltx, Inc.
    Inventor: Mark Williams